Dr. Hopp, together with Dr. Palavicini, co-leads the PLCG2/Alzheimer's/Aging project, funded by the Alzheimer's Association. They currently co-mentor three students and shared co-correspondence in a recent preprint.

Drs. Griffith, Palavicini, and Hopp recently received a pilot grant entitled "Exploring the impact of PLCG2 function and risk variant mutations on T cell tolerance in late-onset Alzheimer's disease".

Dr. Koronowski, together with Dr. Palavicini, co-leads the chronic jet lag/Alzheimer's/Aging project, funded by the William and Ella Owens Medical Research Foundation.

The Palavicini and Goldberg labs are collaborating on a project examining how stroke influences Alzheimer’s disease-related pathologies, leveraging next-generation animal models, advanced imaging platforms, and transcriptomic profiling.

The Palavicini lab is collaborating with the Ruiz lab on a project investigating progranulin levels in human CSF and plasma samples, and its association with proteomic and lipidomic sigantures, as well as Alzheimer's disease-related pathologies.

Drs. Norton and Palavicini have been collaborating since 2020, these efforts have led to two co-authored publications and a preprint.

Dr. Fernandez leads the Nathan Shock Center Integrated Physiology of Aging (IPA) Core. The Palavicini lab is a frequent user of multiple services that the IPA core offers.

Dr. Zadeh is studying the impact of vitamin B12 deficiency in neuro-degenerative diseases. Drs. Zadeh and Palavicini have co-authored one publication and are submitting several MPI grants.